Clinical trial
SARS-CoV-2 Safety Study for the Treatment of COVID-19
NCT06489860 is registered in ClinicalTrials.gov with DHA Coffee Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SARS-CoV-2 Safety Study for the Treatment of COVID-19
- Lead sponsor
- DHA Coffee Co., Ltd
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- January 28, 2025
- Completion date
- February 4, 2025
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
sars-cov-2